The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fahy, R. J.
Right arrow Articles by Wewers, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahy, R. J.
Right arrow Articles by Wewers, M. D.
The Journal of Immunology, 1999, 163: 1755-1762.
Copyright © 1999 by The American Association of Immunologists

Spontaneous Human Monocyte Apoptosis Utilizes a Caspase-3-Dependent Pathway That Is Blocked by Endotoxin and Is Independent of Caspase-11

Ruairi J. Fahy2, Andrea I. Doseff2 and Mark D. Wewers3

Department of Internal Medicine, Division of Pulmonary and Critical Care, and The Heart and Lung Institute, Ohio State University, Columbus, OH 43210


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Apoptosis is an important mechanism for regulating the numbers of monocytes and macrophages. Caspases (cysteine-aspartate-specific proteases) are key molecules in apoptosis and require proteolytic removal of prodomains for activity. Caspase-1 and caspase-3 have both been connected to apoptosis in other model systems. The present study attempted to delineate what role these caspases play in spontaneous monocyte apoptosis. In serum-free conditions, monocytes showed a commitment to apoptosis as early as 4 h in culture, as evidenced by caspase-3-like activity. Apoptosis, as defined by oligonucleosomal DNA fragmentation, was prevented by a generalized caspase inhibitor, z-VAD-FMK, and the more specific caspase inhibitor, z-DEVD-FMK. The caspase activity was specifically attributable to caspase-3 by the identification of cleavage of procaspase-3 to active forms by immunoblots and by cleavage of the fluorogenic substrate DEVD-AFC. In contrast, a caspase-1 family inhibitor, YVAD-CMK, did not protect monocytes from apoptosis, and the fluorogenic substrate YVAD-AFC failed to show an increase in activity in apoptotic monocytes. When cultured with LPS (1 µg/ml), monocyte apoptosis was prevented, as was the activation of caspase-3. Unexpectedly, LPS did not change baseline caspase-1 activity. These findings link spontaneous monocyte apoptosis to the proteolytic activation of caspase-3.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Monocytes play a major role in initiating, maintaining, and resolving host inflammatory responses by differentiating into macrophages and dendritic cells and by releasing cell-signaling molecules, including cytokines. In the absence of inflammation, more monocyte precursors develop from the marrow than are needed to replace normal tissue macrophage numbers (1). However, during inflammatory responses, a dramatic up-regulation of monocyte survival and differentiation may be required. Thus, the processes involved in regulating monocyte removal and survival are critical to population control. The importance of monocyte development and differentiation to disease pathogenesis has recently been highlighted by research in animal models in the field of atherogenesis and osteopetrosis (2, 3).

In the absence of an appropriate stimulus, monocytes spontaneously undergo programmed cell death (4, 5, 6, 7). Recently, a family of cysteine-aspartate-specific proteases called caspases has been found to play a major role in programmed cell death. Within this family, a central role has been suggested for caspase-3 (7, 8, 9, 10, 11) and more controversially for caspase-1 (12, 13, 14, 15, 16, 17, 18, 19, 20, 21). Caspase-1 is the prototypical caspase, which was originally identified as IL-1ß-converting enzyme (ICE)4 (22). Caspase-1 mediates processing of both pro-IL-1ß and pro-IL-18 (23). Additionally, caspase-1 may induce apoptosis, as evidenced by its effect when transfected into fibroblasts and its importance in Fas-mediated apoptosis in caspase-1 knockout animals (12, 13, 14, 15, 16, 17, 18). However, since the discovery of additional ICE-related molecules, other caspases such as caspase-3/CPP32 have been more consistently linked to apoptosis (8).

Generally, caspases exist in cells in an inactive precursor form and require cleavage to generate the active caspase (7). For example, activation of procaspase-3 is tightly regulated by an apoptosis-activating complex, requiring proteolytic removal of an amino-terminal prodomain to produce the active caspase (24, 25, 26, 27). Once activated, caspase-3 performs a number of executioner functions, including the activation of a latent cytosolic endonuclease, caspase-activated deoxyribonuclease (CAD). CAD normally exists intracellularly in an inactive form bound to I-CAD. Caspase-3 cleaves I-CAD, resulting in the release of CAD (28, 29, 30). CAD cleaves DNA into oligonucleosomal fragments that are released into the cytosol. The presence of these cytosolic fragments are landmarks for apoptotic cell death (31, 32).

Due to the importance of caspases in determining either programmed cell death or cytokine activation, we sought to study which caspases are important in human monocyte death and survival. Although previous investigators have shown caspase activity in monocytic cell lines, this is the first study to address the issue in peripheral human monocytes. Our results identify an important role for caspase-3 activity in spontaneous monocyte apoptosis, which is prevented by endotoxin. Interestingly, we fail to identify a role for caspase-1 activation in monocyte death and unexpectedly after endotoxin stimulation. Although LPS protects monocytes from apoptosis and is associated with the processing of pro-IL-1ß, no change in baseline caspase-1 activity is detectable. Conversely, LPS prevents the activation of caspase-3, which is activated spontaneously in fresh blood monocytes.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Monocyte purification

Human monocytes were purified by clumping, as previously described by Graziano and Fanger (33). This method was chosen to limit potential confounding factors involved in other methods of purification, such as adherence or LPS contamination, which may activate cells. Briefly, fresh human monocytes were obtained from normal donors and diluted 1/1 with sterile saline solution. The solution was subsequently centrifuged through a Histopaque-1077 gradient column (Sigma, St. Louis, MO) at 600 x g for 20 min at 4°C. The mononuclear layer was removed, washed, and spun twice in RPMI 1640 (Life Technologies, Grand Island, NY), and the cells were counted. The cells were resuspended in RPMI 1640/10% FBS (HyClone, Logan, UT) at a concentration of 5 x 107 cells/ml. Cells were rotated at 70 rpm on a horizontal rotor for 1 h at 4°C to induce clumping and then sedimented by gravity for 20 min through FBS at 4°C. The sedimented cells were subsequently washed twice in RPMI 1640 and resuspended in RPMI at a final concentration of 1 x 106 cells/ml. The population of monocytes obtained was on average 70–80% pure. In all experiments, monocytes were incubated at a concentration of 1 x 106 cells/ml in serum-free RPMI 1640 at 37°C in 5% CO2. In selected experiments, LPS (LPS Westphal preparation, Escherichia coli 0127:B8; Difco, Detroit, MI) was incubated with monocytes at 1 ng/ml or 1 µg/ml, as indicated.

Caspase inhibitors

The generalized caspase inhibitor z-VAD-FMK (Enzyme Systems Products, Livermore, CA); YVAD-CMK, an ICE/caspase-1 family inhibitor (Calbiochem, San Diego, CA); and z-DEVD-FMK, a caspase-3 family inhibitor (Enzyme Systems Products) were utilized. These inhibitors at 1, 10, and 100 µM in DMSO (Sigma) were added to samples of fresh monocytes and incubated overnight in polypropylene tubes at 37°C in a 5% CO2 environment. A DMSO control (0.1% v/v) was also included as a control for the highest concentration of inhibitors.

Detection of DNA fragmentation

After specific conditions, 4 x 106 monocytes were harvested by centrifugation. The supernatant was removed and monocytes were resuspended in 100 µl of hypotonic lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.9, 10 mM EDTA, 50 µg/ml RNase A) at room temperature for 10 min. Samples were then centrifuged at 16,000 x g, and the supernatant was placed on a DNA Miniprep system (Wizard Plus series SV 9600; Promega, Madison, WI). After washing with 750 µl and 250 µl of 70% ethanol, the DNA was eluted with 100 µl of water at 65°C and concentrated to the desired volume. Samples were mixed with 6x loading dye (BlueJuice; Life Technologies) and loaded onto a 1.8% agarose gel in 1x TAE buffer (40 mM Tris base, 2 mM EDTA, 20 mM glacial acetic acid). The gel was subsequently stained with a 1/10,000 dilution of Syber Green (Molecular Probes, Eugene, OR) in 1x TAE buffer for 30 min to 1 h. The DNA ladders were imaged using a gel imaging system (Bio-Rad, Hercules, CA). A 123-bp DNA marker (Life Technologies) was included.

Preparation of lysates and detection of caspase activity

Enzymatic caspase activity measured with amino trifluoromethyl coumarin (AFC). For all AFC preparations, monocytes (3 x 106 cells) were collected by centrifugation and washed with KPM buffer (50 mM KCl, 50 mM PIPES, 10 mM EGTA, 1.92 mM MgCl2, pH 7.0, 1 mM DTT, 0.1 mM PMSF, 10 µg/ml of cytochalasin B, and 2 µg/ml of protease inhibitors: chymostatin, pepstatin, leupeptin, antipain). Cells were snap frozen in liquid nitrogen and lysed by four cycles of freeze thawing. The presence of active caspases was determined by AFC assay using a specific fluoro-substrate, as previously described (34). Lysates were incubated with DEVD-AFC in a cyto-buffer (10% glycerol, 50 mM PIPES, pH 7, 1 mM EDTA) containing 1 mM DTT and 20 µM DEVD-AFC (Enzyme Systems Products). Extracts were also incubated with YVAD-AFC (Enzyme Systems Products) in a YVAD cyto-buffer (10% sucrose, 100 mM HEPES, pH 7.5, 0.1% CHAPS, 10 mM DTT). Specifically, 20 µM YVAD-AFC was added to lysates and incubated for 45 min at room temperature before measurement. Standard recombinant caspase-1 was a gift from Nancy Thornberry (Merck Research Laboratory, Rahway, NJ). In both instances, release of free AFC was determined using a Cytofluor 4000 fluorometer (Perseptive Diagnostics, Framingham, MA; filters: excitation, 400 nm; emission, 505 nm).

Complexation to biotinylated caspase substrate. Alternatively, active caspases were detected by affinity label, as described by Faleiro et al. (10). Briefly, monocyte pellets were resuspended in KPM buffer and lysed as previously described, but in the presence of 8 µl of 20 µM affinity label solution (biotin-DEVD-aomk or biotin-YVAD-cmk; Biosyn, Belfast, Ireland). Stocks of biotinylated substrates were diluted to 20 µM into MDB buffer (50 mM NaCl, 2 mM MgCl2, 5 mM EGTA, 10 mM HEPES, 1 mM DTT, pH 7). Lysates were incubated for 15 min at 37°C and centrifuged for 20 min at 15,000 x g. Supernatants were mixed with an equal volume of 2x SDS-PAGE buffer (Bio-Rad). Proteins were separated in 15% acrylamide gels by electrophoresis. Gels were transferred to PVDF-PSQ (Millipore, Bedford, MA) for 1 h at 200 mAmp. Membranes were incubated for 20 min with avidin-Neutralite (Molecular Probes) at 1 µg/ml in PT buffer (20 mM Tris, 150 mM NaCl, 0.05% Tween-20) containing 1% BSA (PT-BSA buffer). Membranes were washed in PT buffer and then incubated in biotinylated HRP (Molecular Probes) at 25 ng/ml in PT-BSA buffer. Proteins were visualized by enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL).

Antigenic detection of caspase cleavage products. mAbs that specifically recognize caspase-3 were obtained against purified full-length recombinant protein (gift from Y. Lazebnik, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). Membranes were blocked at 4°C overnight in PT buffer containing 3% milk and 2% BSA (PT-M). Membranes were incubated with anti-caspase 3 Ab (1:1000) for 1 h at room temperature in PT-M buffer with 0.05% Tween-20 (PT-MT). After five washes in PT buffer containing 0.05% Tween-20 (PT-T), membranes were incubated with anti-mouse HRP (1:5000; Amersham) for 1 h in PT-MT buffer. After washing in PT-T buffer, proteins were visualized by ECL (Amersham).

Cytokine measurements

For IL-1ß and IL-8 quantification, LPS (Sigma) at a concentration of 100 ng/ml was added to aliquots of monocyte samples with various concentrations of the caspase inhibitor, YVAD-CMK. Cells were incubated overnight at 37°C in a 5% CO2 environment. Samples were centrifuged at 1200 rpm for 5 min, and the supernatants were removed to a fresh tube. Supernatants were assayed by enzyme-linked immunoassay for both IL-1ß (35) and IL-8 (R &D Systems, Minneapolis, MN) production to assess the specificity of the caspase-1 inhibitor, YVAD-CMK. Samples were read at 450 nm on an automated plate reader (Dynatech MR 600, Chantilly, VA). Results were expressed as percentage of cytokine release in comparison with control cells.

Cell death ELISA

A quantitative enzyme-linked immunoassay (Boehringer Mannheim, Indianapolis, IN) that detects DNA fragments was used following the manufacturer’s recommendations. This detects mono- and oligonucleosomal DNA using the cytoplasmic fractions of cell lysates. Briefly, anti-histone Ab is coated onto a microtiter plate. After a washing step, the wells are incubated with 200 µl of incubation buffer for 30 min. The wells are again washed and incubated with 100 µl of sample for 90 min at room temperature. Following another wash step, the wells are then washed and incubated with 100 µl of anti-DNA peroxidase for an additional 90 min. Addition of substrate solution produces a color change after 10–20 min. This color change is compared with a blank well with substrate added. The plate was read at 405 nm on an automated plate reader (Dynatech MR 600). The assay can detect apoptotic DNA from as little as 50 cells/well.

Flow cytometry analysis

Utilizing an apoptosis detection kit (R&D Systems, Minneapolis, MN), staining of monocytes with both annexin V and propidium iodide was done as recommended by the manufacturers to quantitatively determine the percentage of cells undergoing apoptosis. Briefly, cells were washed with PBS and resuspended in the binding buffer provided. Fluorescein-conjugated annexin V and propidium iodide were incubated for 20 min with monocytes cultured for defined time periods (2–16 h). The monocyte population was selected by gating on CD45/CD14-positive cells (Becton Dickinson Immunocytometry Systems, San Jose, CA) and analyzed on a flow cytometer (FACSCalibur; Becton Dickinson, Franklin Lakes, NJ).

Statistical analysis

All data were expressed as mean ± SEM. Paired t tests were used for single comparisons (Microsoft Excel; Microsoft, Redmond, WA). For comparisons that involved multiple variables and observations, two- and three-way ANOVA (JMP; SAS Institute, Cary, NC) was used. Having passed statistical significance by ANOVA, individual comparisons were made using the contrast method. Statistical significance was defined as a p value <0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Monocytes undergo programmed cell death in the absence of a survival stimulus

Initial studies focused on developing an in vivo system that allowed the study of monocyte apoptosis. When cultured overnight (16 h) in serum-free conditions in the absence of endotoxin, monocytes showed evidence of apoptosis as determined by annexin V staining (Table IGo). We also evaluated monocyte death both by cell death ELISA and oligonucleosomal DNA cleavage. As illustrated in Fig. 1GoA, a greater than 2-fold increase in mono- and oligonucleosomal DNA was seen in monocytes cultured in LPS-free media in contrast to LPS-treated cells (1 ng/ml). In addition, monocytes cultured for 16 h without LPS showed evidence of apoptotic cell death, as indicated by DNA ladder formation, whereas fresh cells (time zero) and LPS (1 µg/ml)-treated cells did not (Fig. 1GoB). Thus, monocytes cultured in the absence of a survival stimulus demonstrate spontaneous apoptosis, which can be prevented by LPS.


View this table:
[in this window]
[in a new window]
 
Table I. Effect of time in culture on percent of monocytes undergoing spontaneous apoptosis1

 


View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 1. Monocyte apoptosis occurs in the absence of a survival stimulus. A, Cell death ELISA. Mono- and oligonucleosomal DNA fragment generation, as detected in cell lysates by ELISA for unstimulated and LPS stimulated (1 ng/ml) monocyte cultures after 16 h. Results are expressed as the mean ± SEM from nine experiments. The asterisk denotes two-tailed Student’s t test, p < 0.02. B, DNA laddering in monocytes. Cytosolic DNA (4 x 106 cells/lane) was purified from monocytes cultured in the presence or absence of LPS (1 µg/ml) and analyzed by agarose gel electrophoresis.

 
Caspase activation is necessary for monocyte apoptosis

To investigate a potential role played by caspases in monocyte apoptosis, we measured the presence of active caspases by a sensitive Western blot technique that labels active caspase with the biotinylated probe DEVD-biotin. This probe labels caspase-3-like molecules (36). Furthermore, we utilized z-VAD-FMK, a generalized irreversible caspase inhibitor that binds to the active site of caspases and blocks their biological activity. Using the DEVD-biotin system, monocytes cultured overnight (DMSO control) demonstrated marked activation of caspase-3-like activity when compared with fresh monocytes (Fig. 2GoA). As expected, increasing doses of z-VAD-FMK prevented detection of active caspase-3 family proteases. Furthermore, consistent with a functional effect of z-VAD-FMK, a progressive dose-dependent decrease in DNA ladder formation was seen with increasing concentrations of z-VAD-FMK (Fig. 2GoB). Therefore, activation of the apoptotic pathway in monocytes, as indicated by DNA ladder formation and caspase activation, can be prevented by a general caspase inhibitor. The suppression by the caspase inhibitor was specific, as a nonblocking peptide FMK substrate (z-Phe-Ala-FMK) did not prevent apoptosis (not shown).



View larger version (68K):
[in this window]
[in a new window]
 
FIGURE 2. Progressive inhibition of monocyte apoptosis by a generalized caspase inhibitor. A, Monocytes were cultured with increasing concentrations of z-VAD-FMK for 16 h. Monocyte lysates were labeled with biotinylated DEVD, and protein was separated by SDS-PAGE (1.5 x 106 cells/lane). The presence of caspase-3-like activity was determined by Western blotting using avidin-biotin labeling. This is representative of two identical experiments. B, Effects of z-VAD-FMK on monocyte oligonucleosomal DNA ladder formation. Monocytes were cultured as in A, and cytosolic DNA was analyzed by agarose gel electrophoresis. Lane 1, fresh monocytes; lanes 2–4, z-VAD-FMK at 1, 10, and 100 µM; and lane 5, DMSO control for z-VAD-FMK diluent. The gel shown is representative of four separate experiments.

 
To determine the kinetics of caspase activation during monocyte apoptosis, cells were incubated for different time periods before lysates were prepared with biotinylated DEVD. Evidence for caspase-3 family activation was seen as early as 4 h in culture (Fig. 3GoA). This caspase-3-like activity correlated with subsequent oligonucleosomal DNA fragmentation. DNA ladders were detected as early as 8 h with a progressively more defined signal up to 16 h in culture (Fig. 3GoB). Thus, caspase-3-like activity is detectable before DNA laddering, which is consistent with the known role of activated caspase-3 in generating oligonucleosomal DNA fragments.



View larger version (54K):
[in this window]
[in a new window]
 
FIGURE 3. Kinetics of monocyte caspase activation and DNA laddering. A, Lysates from monocytes cultured for different time periods were labeled with biotinylated DEVD-aomk. Proteins were separated by SDS-PAGE and detected by immunoblot (1.5 x 106 cells/lane). The blot shown is representative of two identical experiments. B, Monocyte oligonucleosomal DNA ladder formation was determined at similar time points as in A, utilizing agarose gel electrophoresis of cytosolic DNA.

 
Evidence for caspase-3 family activation in monocyte apoptosis

To further define whether caspase-3 family proteases become activated in monocyte apoptosis, we utilized an irreversible inhibitor of caspase-3 family caspases, z-DEVD-FMK. Monocytes were cocultured for 16 h with incremental doses of z-DEVD-FMK. After lysing the cells, active caspases present in the lysates were detected with biotinylated DEVD, as previously described. A dose-response inhibition of active caspase-3 family proteases was seen (Fig. 4GoA). This inhibition of caspase-3 family activity by z-DEVD-FMK correlated with progressive inhibition of oligonucleosomal DNA cleavage (Fig. 4GoB).



View larger version (64K):
[in this window]
[in a new window]
 
FIGURE 4. Inhibition of monocyte apoptosis by a caspase-3 inhibitor. Monocytes were cultured for 16 h in the presence of increasing concentrations of z-DEVD-FMK (0, 1, 10, and 100 µM) or DMSO control. A, Monocyte lysates were labeled with biotinylated DEVD-aomk, separated by SDS-PAGE (1.5 x 106 cells/lane), and transferred to PVDF membrane, and biotinylated caspases were detected by Western blotting. The blot is representative of four different experiments. B, DNA ladder formation. Monocytes from A were also analyzed for DNA ladder formation by agarose gel chromatography of cytosolic DNA. Shown is the effect of increasing concentrations of z-DEVD-FMK (1, 10, and 100 µM).

 
To specifically delineate which of the DEVD-dependent caspases are involved in monocyte apoptosis, an anti-caspase-3/CPP-32 Ab was utilized for Western blotting. The Ab recognizes both the precursor form and the processed forms of caspase-3 (8, 37, 38). With progressive time in culture, a decrease in procaspase-3 is seen with a concomitant increase in the processed fragments (Fig. 5Go). These data suggest that caspase-3 itself is responsible for the z-DEVD-inhibitable activity, consistent with a central role for caspase-3 in monocyte apoptosis.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 5. Caspase-3 is involved in monocyte apoptosis. Lysates from monocytes incubated for different time periods in endotoxin-free RPMI 1640 were separated by SDS-PAGE (3 x 106 cells/lane), blotted onto PVDF membrane, and probed with anti-caspase-3-specific Ab. Proteins were visualized with ECL.

 
The caspase-1 family is not involved in monocyte apoptosis

To determine whether caspase-1 family proteases are necessary for monocyte apoptosis, cells were cultured for 16 h with increasing concentrations of YVAD-CMK (caspase-1-like inhibitor). In contrast to z-VAD-FMK and z-DEVD-FMK, monocytes cultured in the presence of YVAD-CMK showed no protection from apoptosis, as indicated by the presence of DNA laddering at all dose concentrations that were used (Fig. 6GoA). However, YVAD-CMK was physiologically active within monocytes, as was shown by its ability to block mature IL-1ß release in LPS-treated monocytes in a dose-dependent manner while not affecting IL-8 release (Fig. 6Go, C and D). As further evidence that the caspase-1 family does not play a role in this model of monocyte apoptosis, we determined caspase-1 activity in monocyte cultures at various time points utilizing a fluorogenic substrate. This peptide-tagged fluorogenic substrate is recognized by the catalytic site of active caspase-1 family proteases resulting in fluorescence. YVAD-AFC added to lysates showed no change in activity after 16 h in culture compared with baseline (Fig. 6GoB). That YVAD-AFC could detect active caspase-1 was shown by its ready cleavage by recombinant caspase-1 in control experiments (Fig. 6GoE). In contrast, when DEVD-AFC (fluorogenic substrate for active caspase-3 family) was added to cell lysates, a 6-fold increase in activity was seen in cells cultured for longer than 4 h (Fig. 6GoB). This activity remained high at 16 h in agreement with our previous results (Fig. 3GoA).



View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 6. Role of caspase-1 in monocyte apoptosis. A, Effect of YVAD-CMK on monocyte apotosis. Monocytes were incubated with increasing concentrations of YVAD-CMK (0, 1, 10, and 100 µM or DMSO control). Samples were analyzed after 16 h in culture for DNA ladder formation, as described in Fig. 1Go. This is representative of four identical experiments. B, Monocyte caspase activity over time in culture. Monocytes were incubated for various time periods. Lysates were analyzed for the presence of caspase-1 and caspase-3 activity using fluorogenic substrates, YVAD-AFC (open symbols) and DEVD-AFC (filled symbols), respectively. Two separate donors were studied (donor 1, circle; donor 2, square). C, Effect of YVAD-CMK (caspase-1 inhibitor) on monocyte IL-1ß release (n = 5). Monocytes were incubated overnight with the inhibitor in the presence of LPS (100 ng/ml). Results are expressed as percentage of control. ANOVA results for IL-1ß release in the presence of YVAD-CMK revealed a p value <0.001. Individual comparisons were statistically different from baseline (p value <0.001, denoted by asterisks). D, Effect of YVAD-CMK on IL-8 production (n = 5). Monocytes were cultured as in C, and IL-8 release was determined by ELISA, with results being expressed as percentage of control. ANOVA results for IL-8 release in the presence of YVAD-CMK did not reach statistical significance (p = 0.96). E, Detection of purified ICE activity with YVAD-AFC. Cleavage of YVAD-AFC substrate with various concentrations of recombinant caspase-1 is shown.

 
LPS protects monocytes from apoptosis through a caspase-3-dependent pathway

As shown previously (Fig. 1Go), LPS protected monocytes from apoptosis. To determine whether LPS had effects on caspase activity, monocytes were incubated in the presence or absence of LPS for 0 and 16 h. Lysates were analyzed with both YVAD-AFC and DEVD-AFC. Caspase-1-like activity did not change in the presence or absence of LPS, from time 0 to 16 h in culture. In contrast, caspase-3-like activity in non-LPS-treated cells increased more than 4-fold from time 0 to 16 h in culture. In LPS-treated cells, no significant change was seen in caspase-3-like activity during this time period (Fig. 7Go). These data suggest that LPS protected monocytes from undergoing apoptosis at least partially by regulating caspase-3-like activity.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 7. Effect of LPS on monocyte apoptosis. Monocytes were incubated with or without endotoxin (LPS, 1 µg/ml). Lysates were prepared from monocytes harvested fresh or after 16 h in culture. The presence of caspase-1- and caspase-3-like activity was determined using fluorogenic substrates YVAD-AFC (open bars) and DEVD-AFC (filled bars), respectively. Results are expressed as the mean ± SEM from three separate experiments. When analyzed by both two- and three-way analysis of variance for the effect of LPS, time, and caspase type, the p value was <0.015. For individual comparisons, DEVD-AFC activity was significantly increased at 16 h vs 0 h (p < 0.001). Comparisons are denoted by an asterisk. There was no such increase at 16 h with LPS for DEVD-AFC (p = 0.33, denoted by ¶), nor for YVAD-AFC comparisons with time and LPS variables.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Apoptosis is a cell suicide program that has been conserved through evolution. It results in the cell death through a tightly regulated process resulting in the removal of damaged or unwanted tissue without eliciting an inflammatory response. The processes that elicit activation of the apoptotic program are diverse. The present study asks the question of what role caspases play in monocytes undergoing spontaneous apoptosis in vitro. It further defines the specific roles of caspase-3 and caspase-1 in monocyte apoptosis and in LPS activation.

In agreement with previous observations, we found that monocytes can be prevented from undergoing apoptosis with the addition of endotoxin to cell culture (4, 5). In the absence of a survival stimulus, monocytes undergo programmed cell death. Consistent with previous studies, it is evident that apoptotic monocytes show characteristic changes on electron microscopy and demonstrate oligonucleosomal DNA fragments on DNA gel electrophoresis (4, 5, 32). To demonstrate the role played by caspases, we utilized a biotinylated caspase-3 substrate. As shown in Fig. 3Go, caspase activity precedes DNA laddering, which is consistent with reports that caspase activation is required for DNA fragmentation (28). As has been previously reported in monocytic tumor cell lines, we show that monocyte apoptosis can be prevented by inhibition of caspase activity with a generalized inhibitor, z-VAD-FMK (39). Subsequently, we demonstrate inhibition of monocyte apoptotic cell death with a caspase-3 family inhibitor, z-DEVD-FMK, but not with a caspase-1 family inhibitor, YVAD-CMK. Fluorogenic substrates also show increased caspase-3-like activity with time, but no change in caspase-1-like activity. As further proof of the specific role of caspase-3 in apoptosis, we found progressive activation of caspase-3 with time in culture by using an anti-caspase-3 Ab. This is consistent with previous work in hemopoietic stem cell lines and other cell lines, which link caspase-3 with apoptosis (9, 10, 40, 41). These findings, however, question the role of caspase-1/ICE in monocyte apoptosis. The lack of caspase-1 activity in monocyte apoptosis contrasts with previous studies in cell lines and knockout models, which support its role in apoptosis (12, 13, 14, 15, 16, 17, 18, 19, 20, 21). Because the closest link between apoptosis and caspase-1 involves the Fas system, it is conceivable that spontaneous human monocyte apoptosis is caspase-1 independent, while Fas-mediated apoptosis may use a caspase-1 pathway. This hypothesis needs to be confirmed, but finds support from studies in ICE knockout mice that demonstrate resistance to Fas-mediated apoptosis, but remain sensitive to apoptosis induced by other stimuli (13).

It had previously been believed that removal of cytokine stimulation from a hemopoietic cell caused cessation of a survival-signaling pathway, resulting in death of the cell. By comparing DEVD-AFC activity in cell cultures at time 0 and after 16 h, in the presence or absence of LPS (survival stimulus), we demonstrated that in the absence of LPS (i.e., loss of a survival signal), a dramatic increase in active caspase-3 family activity occurred, resulting in apoptotic cell death. Thus, LPS appears to prevent apoptosis by inhibition of activation of the caspase death cascade. It is particularly noteworthy that we did not detect any significant change in caspase-1 activity with LPS. This was unexpected considering that LPS stimulates mature IL-1ß production and requires caspase-1/ICE for processing pro-IL-1ß to its active form. Nevertheless, we and others have failed to detect caspase-1/ICE activity in human monocytes, macrophages, and THP-1 cell lines (42, 43). The lack of caspase-1 activity may be due to insufficient sensitivity. However, our data do show low, but detectable activity, even at baseline, using the YVAD-AFC substrate. Singer et al. (44) has previously shown evidence of caspase-1 activity in monocytes of both LPS-treated and control monocytes by immunoelectron microscopy. Taken together, these findings suggest that caspase-1 activity may exist constitutively in a specialized compartment. Thus, pro-IL-1ß processing may not be regulated at the level of caspase-1 activation, but by access of pro-IL-1ß to the active caspase-1/ICE compartment. The regulation of caspase-1 remains an area of active investigation.

The caspase-1 and caspase-3 families may have roles other than in the apoptotic program. For example, in THP-1 monocytic cells, caspase-1 cleaves pro-IL-18 to a biologically active mature IL-18 (23). In contrast, caspase-3 was found to cleave precursor and mature IL-18 to biologically inactive units. IL-18 has numerous immunologic functions, which include enhancing NK cell cytotoxicity and stimulating IFN-{gamma} and GM-CSF production by monocytes, both of which can act as a survival signal. In this situation, it would appear that caspase-3 may down-regulate the inflammatory response. Additionally, another proinflammatory cytokine, IL-16, is also cleaved by caspase-3 in both COS cells and lymphocytes to its mature active form. We suggest that caspase activation in lymphocytes may result in activation of pathways other than apoptosis (45). To date, in monocytes a role for caspase-3 other than in apoptosis has not been defined.

Although our findings point to a critical role for caspase-3 in monocyte apoptosis, it does not rule out the possibility that other caspase-3 family proteases also play a crucial role in monocyte apoptosis. For example, caspase-6 and caspase-7 also may be inhibited by z-DEVD-FMK. Nevertheless, our results do show evidence that caspase-3 itself is cleaved in the process of monocyte apoptosis, which suggests it is responsible for the DEVD-AFC activity (Fig. 5Go).

In conclusion, in the absence of an inflammatory stimulation, monocytes undergo spontaneous apoptosis characterized by activation of caspase-3 and oligonucleosomal DNA ladder formation. This apoptosis program is prevented by the addition of LPS or specific inhibitors of caspase-3.


    Acknowledgments
 
We thank Thomas L. Clanton, Clay B. Marsh, James E Gadek, and Veela Mehta for their comments and support.


    Footnotes
 
1 This work is supported by National Institutes of Health Grants HL40871 and HL53229. R.J.F. is a Glaxo-Wellcome Pulmonary Fellowship recipient for 1998. Back

2 R.J.F. and A.I.D. contributed equally to this study. Back

3 Address correspondence and reprint requests to Dr. Mark D. Wewers, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Ohio State University, N-325 Means Hall, 1654 Upham Drive, Columbus OH 43210. E-mail address: Back

4 Abbreviations used in this paper: ICE, IL-1ß-converting enzyme; AFC, amino trifluoromethyl coumarin; CAD, caspase-activated deoxyribonuclease; PVDF, polyvinylidene difluoride; DEVD, Asp-Glu-Val-Asp; YVAD, Tyr-Val-Ala-Asp; CMK, chloromethyl ketone; FMK, fluoromethyl ketone; aomk, acyloxymethyl ketone. Back

Received for publication November 25, 1998. Accepted for publication May 27, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ralph, P.. 1989. Colony stimulating factors. eds. Human Monocytes 227. Academic Press, New York.
  2. Lagasse, E., I. L. Weissman. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021.[Medline]
  3. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92:8264.[Abstract/Free Full Text]
  4. Mangan, D. F., G. R. Welch, S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-{alpha}, and IL-1ß prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.[Abstract]
  5. Mangan, D. F., S. M. Wahl. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147:3408.[Abstract]
  6. Mangan, D. F., S. E. Mergenhagen, S. M. Wahl. 1993. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J. Periodontol. 64:461.[Medline]
  7. Thornberry, N. A., Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312.[Abstract/Free Full Text]
  8. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, et al 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37.[Medline]
  9. Ohta, T., T. Kinoshita, M. Naito, T. Nozaki, M. Masutani, T. Tsuruo, A. Miyajima. 1997. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J. Biol. Chem. 272:23111.[Abstract/Free Full Text]
  10. Faleiro, L., R. Kobayashi, H. Fearnhead, Y. Lazebnik. 1997. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16:2271.[Medline]
  11. Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T. T. Yamin, D. W. Nicholson. 1996. CPP32/apopain is a key interleukin 1ß converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1841.[Abstract/Free Full Text]
  12. Miura, M., H. Zhu, R. Rotello, E. A. Hartwieg, J. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1ß-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653.[Medline]
  13. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1ß converting enzyme. Science 267:2000.[Abstract/Free Full Text]
  14. Enari, M., H. Hug, S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78.[Medline]
  15. Shi, L., G. Chen, G. MacDonald, L. Bergeron, H. Li, M. Miura, R. J. Rotello, D. K. Miller, P. Li, T. Seshadri, et al 1996. Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc. Natl. Acad. Sci. USA 93:11002.[Abstract/Free Full Text]
  16. Friedlander, R. M., V. Gagliardini, R. J. Rotello, J. Yuan. 1996. Functional role of interleukin 1ß (IL-1ß) in IL-1ß-converting enzyme-mediated apoptosis. J. Exp. Med. 184:717.[Abstract/Free Full Text]
  17. Greidinger, E. L., D. K. Miller, T. T. Yamin, L. Casciola-Rosen, A. Rosen. 1996. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390:299.[Medline]
  18. Enari, M., R. V. Talanian, W. W. Wong, S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.[Medline]
  19. Los, M., M. Van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. Baeuerle, W. Droge, P. H. Krammer, W. Fiers, K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375:81.[Medline]
  20. Kondo, T., T. Yokokura, S. Nagata. 1997. Activation of distinct caspase-like proteases by Fas and reaper in Drosophila cells. Proc. Natl. Acad. Sci. USA 94:11951.[Abstract/Free Full Text]
  21. MacFarlane, M., K. Cain, X. M. Sun, E. S. Alnemri, G. M. Cohen. 1997. Processing/activation of at least four interleukin-1ß converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 137:469.[Abstract/Free Full Text]
  22. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al 1992. A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes. Nature 356:768.[Medline]
  23. Akita, K., T. Ohtsuki, Y. Nukada, T. Tanimoto, M. Namba, T. Okura, R. Takakura-Yamamoto, K. Torigoe, Y. Gu, M. S.-S. Su, et al 1997. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin-18 in monocytic THP1 cells. J. Biol. Chem. 272:26595.[Abstract/Free Full Text]
  24. Chinnaiyan, A. M., K. O’Rourke, B. R. Lane, V. M. Dixit. 1997. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275:1122.[Abstract/Free Full Text]
  25. Vaux, D. L.. 1997. CED-4: the third horseman of apoptosis. Cell 90:389.[Medline]
  26. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405.[Medline]
  27. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479.[Medline]
  28. Liu, X., H. Zou, C. Slaughter, X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175.[Medline]
  29. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43.[Medline]
  30. Sakahira, H., M. Enari, S. Nagata. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96.[Medline]
  31. Kroemer, G., P. Petit, N. Zamzami, J. L. Vayssiere, B. Mignotte. 1995. The biochemistry of programmed cell death. FASEB J. 9:1277.[Abstract]
  32. Liepins, A., J. O. Bustamante. 1994. Cell injury and apoptosis. Scanning Microsc. 8:631.[Medline]
  33. Graziano, R. F., M. W. Fanger. 1987. Fc{gamma}RI and Fc{gamma}RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol. 139:3536.[Abstract]
  34. Thornberry, N. A.. 1994. Interleukin-1ß converting enzyme. Methods Enzymol. 244:615.[Medline]
  35. Wewers, M. D., D. J. Herzyk. 1989. Alveolar macrophages differ from blood monocytes in human interleukin 1ß release: quantitation by enzyme linked immunoassay. J. Immunol. 143:1635.[Abstract]
  36. Thornberry, N. A., T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P.A. Nordstrom, S. Roy, J. P. Vaillancourt, et al 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272:17907.[Abstract/Free Full Text]
  37. Tewari, M., L. T. Quan, K. O’Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, V. M. Dixit. 1995. Yama/CPP32 ß, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801.[Medline]
  38. Fernandes-Alnemri, T., R. C. Armstrong, J. Krebs, S. M. Srinivasula, L. Wang, F. Bullrich, L. C. Fritz, J. A. Trapani, K. J. Tomaselli, G. Litwack, E. S. Alnemri. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93:7464.[Abstract/Free Full Text]
  39. Slee, E. A., H. Zhu, S. C. Chow, M. MacFarlane, D. W. Nicholson, G. M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD. FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21.
  40. Polverino, A. J., S. D. Patterson. 1997. Selective activation of caspases during apoptotic induction in HL-60 cells: effects of a tetrapeptide inhibitor. J. Biol. Chem. 272:7013.[Abstract/Free Full Text]
  41. Dubrez, L., I. Savoy, A. Hamman, E. Solary. 1996. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15:5504.[Medline]
  42. Wewers, M. D., H. A. Dare, A. V. Winnard, J. M. Parker, D. K. Miller. 1997. IL-1ß converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1ß release is ICE independent. J. Immunol. 159:5964.[Abstract]
  43. Ayala, J. M., T.-T. Yamin, L. A. Egger, J. Chin, J. Kostura, D. K. Miller. 1994. IL-1ß converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153:2592.[Abstract]
  44. Singer, I. I., S. Scott, J. Chin, E. K. Bayne, G. Limjuco, J. Weidner, D. K. Miller, K. Chapman, J. Kostura. 1995. The interleukin-1ß-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182:1447.[Abstract/Free Full Text]
  45. Zhang, Y., D. M. Center, M. H. Wu, W. W. Cruikshank, J. Yuan, D. W. Andrews, H. Kornfeld. 1998. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273:1144.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Nicholas, S. Batra, M. A. Vargo, O. H. Voss, M. A. Gavrilin, M. D. Wewers, D. C. Guttridge, E. Grotewold, and A. I. Doseff
Apigenin Blocks Lipopolysaccharide-Induced Lethality In Vivo and Proinflammatory Cytokines Expression by Inactivating NF-{kappa}B through the Suppression of p65 Phosphorylation
J. Immunol., November 15, 2007; 179(10): 7121 - 7127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. H. Voss, S. Batra, S. J. Kolattukudy, M. E. Gonzalez-Mejia, J. B. Smith, and A. I. Doseff
Binding of Caspase-3 Prodomain to Heat Shock Protein 27 Regulates Monocyte Apoptosis by Inhibiting Caspase-3 Proteolytic Activation
J. Biol. Chem., August 24, 2007; 282(34): 25088 - 25099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Wang, M. M. Zeigler, G. K. Lam, M. G. Hunter, T. D. Eubank, V. V. Khramtsov, S. Tridandapani, C. K. Sen, and C. B. Marsh
The Role of the NADPH Oxidase Complex, p38 MAPK, and Akt in Regulating Human Monocyte/Macrophage Survival
Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Sarkar, M. W. Hall, M. Exline, J. Hart, N. Knatz, N. T. Gatson, and M. D. Wewers
Caspase-1 Regulates Escherichia coli Sepsis and Splenic B Cell Apoptosis Independently of Interleukin-1beta and Interleukin-18
Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Oksjoki, P. T. Kovanen, K. A. Lindstedt, B. Jansson, and M. O. Pentikainen
OxLDL-IgG Immune Complexes Induce Survival of Human Monocytes
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 576 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. H. Voss, S. Kim, M. D. Wewers, and A. I. Doseff
Regulation of Monocyte Apoptosis by the Protein Kinase C{delta}-dependent Phosphorylation of Caspase-3
J. Biol. Chem., April 29, 2005; 280(17): 17371 - 17379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Denlinger, G. Angelini, K. Schell, D. N. Green, A. G. Guadarrama, U. Prabhu, D. B. Coursin, P. J. Bertics, and K. Hogan
Detection of Human P2X7 Nucleotide Receptor Polymorphisms by a Novel Monocyte Pore Assay Predictive of Alterations in Lipopolysaccharide-Induced Cytokine Production
J. Immunol., April 1, 2005; 174(7): 4424 - 4431.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Wu, R. D. Mosteller, and D. Broek
Sphingosine Kinase Protects Lipopolysaccharide-Activated Macrophages from Apoptosis
Mol. Cell. Biol., September 1, 2004; 24(17): 7359 - 7369.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Wei, J. Guo, A. I. Doseff, D. F. Kusewitt, A. K. Man, R. G. Oshima, and M. C. Ostrowski
Activated Ets2 Is Required for Persistent Inflammatory Responses in the Motheaten Viable Model
J. Immunol., July 15, 2004; 173(2): 1374 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Wewers
IL-1{beta}: An endosomal exit
PNAS, July 13, 2004; 101(28): 10241 - 10242.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. Elssner, A. I. Doseff, M. Duncan, M. Kotur, and M. D. Wewers
IL-16 Is Constitutively Present in Peripheral Blood Monocytes and Spontaneously Released During Apoptosis
J. Immunol., June 15, 2004; 172(12): 7721 - 7725.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. I. Doseff, J. H. Baker Jr., T. A. Bourgeois, and M. D. Wewers
Interleukin-4-Induced Apoptosis Entails Caspase Activation and Suppression of Extracellular Signal-Regulated Kinase Phosphorylation
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Park, A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles
Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages
J. Immunol., June 15, 2003; 170(12): 6209 - 6216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Zeigler, A. I. Doseff, M. F. Galloway, J. M. Opalek, P. T. Nowicki, J. L. Zweier, C. K. Sen, and C. B. Marsh
Presentation of Nitric Oxide Regulates Monocyte Survival through Effects on Caspase-9 and Caspase-3 Activation
J. Biol. Chem., April 4, 2003; 278(15): 12894 - 12902.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Carracedo, R. Ramirez, S. Soriano, A. Martin-Malo, M. Rodriguez, and P. Aljama
Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic haemodialysis membranes
Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1971 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. J. Hathaway, G. E. Griffin, P. J. Sansonetti, and J. D. Edgeworth
Human Monocytes Kill Shigella flexneri but Then Die by Apoptosis Associated with Suppression of Proinflammatory Cytokine Production
Infect. Immun., July 1, 2002; 70(7): 3833 - 3842.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lang, F. Dohle, M. Terstesse, P. Bangen, C. August, H.-G. Pauels, and S. Heidenreich
Down-Regulation of Monocyte Apoptosis by Phagocytosis of Platelets: Involvement of a Caspase-9, Caspase-3, and Heat Shock Protein 70-Dependent Pathway
J. Immunol., June 15, 2002; 168(12): 6152 - 6158.
[Abstract] [Full Text] [PDF]


Home page